M & C Children's Clinic

M & C Children's Clinic was paid $2.51M by Medicaid between Oct 2018 and Oct 2024, across 73 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 18% of everything it billed.

33Billing provider infoM & C CHILDREN'S CLINIC
EL PASO, TX 79936

33aNPI1356419832assigned 12/01/2006

33bProvider typePediatrics Physician

28Total paid$2.51M

24GClaims86,631

24DCodes billed73

24AFirst – last monthOct 2018 – Oct 2024

Compared with peers

Next to other Pediatrics Physician providers in Texas

Rank by total paid#190 of 1,136

Median peer was paid$329K

This provider vs. median7.6×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	26	$1K
2019	114	$4K
2020	5,391	$140K
2021	23,701	$705K
2022	23,515	$684K
2023	21,552	$580K
2024incomplete	12,332	$392K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99213	Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity	18%	11,574	10,068	$441K
99214	Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity	15%	6,878	6,333	$369K
99393	Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years)	10%	2,851	2,769	$252K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	8.8%	1,700	1,571	$220K
99394	Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years)	8.4%	2,265	2,198	$210K
99392	Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years)	8.3%	2,528	2,395	$208K
99391	Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year)	6.8%	2,219	1,907	$171K
90460	Immunization administration through 18 years of age via any route, first or only component	6.7%	15,296	7,060	$168K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	4.5%	4,490	4,182	$112K
99429		2.8%	2,192	2,046	$70K
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	1.6%	1,472	1,404	$41K
99000		1.1%	2,743	2,563	$29K

61 more codes

87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	1.1%	1,082	$27K
96110	Developmental screening, with scoring and documentation, per standardized instrument	<1%	2,457	$21K
90461		<1%	2,155	$17K
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,103	$15K
92552		<1%	902	$15K
0071A		<1%	263	$11K
0072A		<1%	251	$10K
90472	Immunization administration, each additional vaccine (list separately)	<1%	1,163	$10K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	120	$9K
87804	Infectious agent antigen detection by immunoassay; Influenza, each type	<1%	461	$9K
99239	Hospital discharge day management, more than 30 minutes	<1%	115	$9K
0002A		<1%	154	$6K
0001A		<1%	160	$6K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	515	$6K
87631		<1%	47	$5K
96160		<1%	2,747	$5K
83655		<1%	457	$5K
99460		<1%	55	$4K
0053A		<1%	50	$2K
87634		<1%	45	$2K
94060		<1%	45	$2K
87807		<1%	150	$2K
90670		<1%	1,173	$2K
90651		<1%	928	$1K
0003A		<1%	38	$1K
90620		<1%	444	$1K
99383		<1%	12	$1K
0073A		<1%	32	$1K
0081A		<1%	32	$1K
90734		<1%	699	$1K
G8510	Screening for depression is documented as negative, a follow-up plan is not required	<1%	106	$1K
99173		<1%	1,147	$1K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	101	$998.56
81000		<1%	565	$788.06
90686		<1%	2,761	$786.57
90671		<1%	592	$738.61
90480		<1%	13	$443.00
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	244	$379.70
90680		<1%	1,198	$333.48
90633		<1%	895	$209.37
90648		<1%	1,288	$189.04
90716		<1%	152	$163.34
99001		<1%	25	$111.78
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	13	$109.47
90707		<1%	157	$94.15
90698		<1%	203	$89.66
90723		<1%	780	$75.06
90715		<1%	217	$73.17
90696		<1%	181	$57.03
90700		<1%	183	$27.63
85014		<1%	15	$8.60
J7611	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg	<1%	22	$3.07
J7613	Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg	<1%	14	$0.34
91307		<1%	671	$0.17
90656		<1%	194	$0.08
90619		<1%	32	$0.05
91305		<1%	199	$0.03
91308		<1%	85	$0.03
90710		<1%	144	$0.01
91300		<1%	308	$0.01
A4550	Surgical trays	0%	63	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialUSEN, STANLEY (PRESIDENT)